Role of CD44 expression in non-tumor tissue on intrahepatic recurrence of hepatocellular carcinoma (Q43439182)

23 November 2017

Role of CD44 expression in non-tumor tissue on intrahepatic recurrence of hepatocellular carcinoma (English)

1 reference

23 November 2017

Lkhagva-Ochir Tovuu

1

1 reference

23 November 2017

Satoru Imura

2

1 reference

23 November 2017

Tohru Utsunomiya

3

1 reference

23 November 2017

Yuji Morine

4

1 reference

23 November 2017

Tetsuya Ikemoto

5

1 reference

23 November 2017

Yusuke Arakawa

6

1 reference

23 November 2017

Hiroki Mori

7

1 reference

23 November 2017

Jun Hanaoka

8

1 reference

23 November 2017

Mami Kanamoto

9

1 reference

23 November 2017

Koji Sugimoto

10

1 reference

23 November 2017

Shuichi Iwahashi

11

1 reference

23 November 2017

Yu Saito

12

1 reference

23 November 2017

Shinichiro Yamada

13

1 reference

23 November 2017

Michihito Asanoma

14

1 reference

23 November 2017

Hidenori Miyake

15

1 reference

23 November 2017

Mitsuo Shimada

16

1 reference

23 November 2017

16 June 2012

1 reference

International Journal of Clinical Oncology

23 November 2017

1 reference

23 November 2017

18

1 reference

23 November 2017

4

1 reference

23 November 2017

651-656

1 reference

https://scigraph.springernature.com/pub.10.1007/s10147-012-0432-6

23 November 2017

0 references

cites work

Hepatocellular carcinoma: present status and future prospects

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

Focus on hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

The actual five-year survival rate of hepatocellular carcinoma patients after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

Role of CD44 variant exon 6 in acute lymphoblastic leukaemia: association with altered bone marrow localisation and increased tumour burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

CD44: from adhesion molecules to signalling regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

CD133+CD44+ population efficiently enriches colon cancer initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

CD44 and its partners in metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

CD44 and EpCAM: cancer-initiating cell markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0432-6

CD44 variant exons in leukemia and lymphoma

21 January 2018

1 reference

12 December 2020

Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival

1 reference

12 December 2020

To metastasize or not? Selection of CD44 splice sites

1 reference

12 December 2020

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

1 reference

12 December 2020

CD44 and hematologic malignancies.

1 reference

12 December 2020

Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma

1 reference

12 December 2020

Expression of CD44 variant isoforms in malignant melanoma

1 reference

12 December 2020

10.1007/S10147-012-0432-6

Identifiers

DOI

1 reference

Dimensions Publication ID

23 November 2017

0 references

1 reference